KEY RECOMMENDATIONS FOR MALARIA TREATMENT & PREVENTION

Diagnosis: prompt ┬ádiagnosis by microscopy or rapid diagnostic tests (RDTs) is required in all patients suspected of malaria before treatment Artemisinin-based combination therapy (ACT) is recommended as first-line curative treatment for uncomplicated P. falciparum malaria and should be given for at least 3 days. Artemether-Lumefantrine (AL) is drug of choice with Artesunate-Amodiaquine (AS-AQ) as alternate Avoid monotherapy, it promotes resistance. Artemisinin and its derivatives should not be used as monotherapy for uncomplicated malaria. Chloroquine and Sulfadoxine-Pyrimethamine are no longer recommended for the treatment of malaria in Nigeria due to the prevailing high levels of resistance which have compromised their efficacy even in combinations. 🤰In pregnancy, the first-line treatment for uncomplicated P. falciparum malaria in the first trimester is Quinine + Clindamycin given for 7 days. ACT may be used if Quinine is not available. In the second and third trimesters, ACT (AL or AS-AQ) is the first-line treatment for uncomplicated P. falciparum malaria 🤱In breastfeeding mothers, ACT (AL or AS-AQ) is the first-line treatment for uncomplicated P. falciparum malaria

Be the first to comment

Leave a Reply

Your email address will not be published.


*